| You are in:Home/Publications/The Effectiveness of Low-Dose Colchicine in the Treatment of Steroid- Resistant Primary Focal Segmental Glomerulosclerosis | |
Assist. hanan kamal abd elkader mohamed tobaa :: Publications: |
|
| Title: | The Effectiveness of Low-Dose Colchicine in the Treatment of Steroid- Resistant Primary Focal Segmental Glomerulosclerosis |
| Authors: | Hanan Kamal Abdelkader El-Metwaly Lotfy El ShahawyMohamed El Tantawy EbrahimShaimaa Mostafa Mohamed |
| Year: | 2026 |
| Keywords: | Not Available |
| Journal: | Not Available |
| Volume: | Not Available |
| Issue: | Not Available |
| Pages: | Not Available |
| Publisher: | Not Available |
| Local/International: | Local |
| Paper Link: | Not Available |
| Full paper | hanan kamal abd elkader mohamed tobaa_Ay-T-83-Hanan kamal Abdelkader-plag Paper (6) -11-7-2025-2 (1).docx |
| Supplementary materials | Not Available |
| Abstract: |
Background: Focal Segmental Glomerulosclerosis (FSGS) is a rare condition that is detected in only 9% of all kidney biopsies. with consistent rates in recent years. This study aimed to investigate the effect of low dose colchicine (LODOCO) (0.5mg once daily) as Add-On therapy on the response and progression of steroid resistant primary FSGS in patients receiving standard care. Methods: The study was carried on 40 patients with primary FSGS resistant to corticosteroids admitted to Nephrology Department at Benha University Hospitals. Results: The eGFR was significantly increased during follow-up (P |
